Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Government-funded gene therapy trial for blindness successful

Government-funded gene therapy trial for blindness successful

29th April 2008

The Department of Health has announced that a government-funded trial to administer gene therapy to the human retina to treat blindness has proven successful.

A total of one million pounds of government funding supported the trial conducted at the Moorfields Eye Hospital/UCL Institute of Ophthalmology National Institute for Health Research Biomedical Research Centre.

The trial showed a significant improvement in the sight of a patient with a type of inherited retinal degeneration called Leber’s congenital amaurosis that causes progressive deterioration in vision and blindness in teenagers.

Dawn Primarolo, public health minister, said: “This is a major achievement for British science and the NHS and shows we truly are at the forefront of innovation.

“The success of this research has huge implications for sufferers of this condition, as well as for a much larger group of inherited retinal diseases which affect one in 3,000 people.”

She added that this type of research is key for the health and wellbeing of the UK, with the government’s funding of the National Institute for Health Research underlining the contribution of the NHS to scientific excellence across the globe.

In May 2007, health minister Lord Hunt reported that the UK leads Europe in gene therapy, with over 40 per cent of clinical trials, being second only to the US in this sphere.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.